Drug Discovery World

APRIL 29, 2024

Dr Currien MacDonald, Medical Chair Director at WCG, discusses the challenges and opportunities presented by cannabis research. Research support Support for researching cannabidiol is expanding. More importantly, cannabis research received additional governmental support for continued investigation at the end of 2022 with H.R.8454,

Research 147

Research FDA Production Drug Development 147

KIF1A

MARCH 2, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development.

Laboratories 119

Laboratories Cell Biology Disease Research 119

Fierce BioTech

JUNE 14, 2024

How AI Accelerates Clinical & Drug Development Timelines pesurya Fri, 06/14/2024 - 10:59 Wed, 09/11/2024 - 14:00 Resource Type Webinar Viswa Colluru, Ph.D. Embrace this opportunity to stay ahead and lead in a rapidly evolving field by registering for this exclusive webinar sponsored by Dr. Vince Clinical Research.

Drug Development 52

Drug Development Clinical Research Drugs Research 52

Drug Discovery World

MARCH 25, 2024

“The potential for CAR T as a therapeutic option for autoimmune disease has captured the collective imagination of the scientific community,” said Zachary Roberts, Executive Vice President of Research & Development and Chief Medical Officer of Allogene.

Drugs 130

Drugs Licensing Licensing Laboratories 130

Perficient: Drug Development

MAY 28, 2024

On Sunday, May 19th, 2024, 21 individuals consisting of Perficient employees and their family members, participated in the 2024 Michigan Kidney Walk at the Detroit Zoo. More than 80 cents of every dollar raised goes to research, patient services, professional education, public health education, and community services.

Disease 98

Disease Research 98

KIF1A

MAY 31, 2024

Our mission to accelerate research and find a cure for KIF1A Associated Neurological Disorder (KAND) remains our guiding light. Call to Action: Natural History Study Enrollment We urgently need your help to accelerate our research. 6/27 Fundraising Strategy Session : Join us to learn how you can help raise funds for our mission!

Treatment 52

Treatment Hospitals Research Science 52

Alta Sciences

JANUARY 22, 2024

Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Alta Sciences

APRIL 11, 2024

What does change in drug development look like? aasimakopoulos Thu, 04/11/2024 - 23:52 HTML Disrupting the CRO Model: A 2024 Global Health Summit Documentary Can the drug development industry change for the better? Contact us to get started! What is the Global Health Summit? Discover the series.

Drug Development 52

Drug Development Drugs Research 52

LifeSciVC

JANUARY 16, 2024

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Let’s agree to make 2024 the year we take action and voice concerns for legislation that encumbers the ability for biotech to deliver on its promise to patients and caregivers.

Small Molecule 139

Small Molecule Trials Therapies Disease 139

Fierce BioTech

MARCH 12, 2024

Listing Image PPD-TF-logo.png Listing Introduction Get the latest FSP trends, strategies, and projections for biopharma and biotech companies as Lori Boyce, Vice President, PPD FSP Solutions, and Mike Lydon, Director, PPD FSP Solutions, share findings from The 2024 FSP Trends Report. On Demand Start Date Thu, 04/11/2024 - 12:00

Clinical Research 52

Clinical Research Drug Development Trials Research 52

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Five Predictions for the Drug Development Industry in 2024 1.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Drug Discovery World

JANUARY 2, 2024

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. As for Infinitopes, the company’s trials will begin in 2024.

Research 147

Research Vaccine Science Trials 147

Drug Discovery World

FEBRUARY 16, 2024

DDW recently hosted an online event, sponsored by Taconic Biosciences, which outlined areas of advancement and opportunity in the cancer research market. New drug discovery and development concepts The event started with a panel discussion on new drug discovery and development concepts and tools in cancer research.

Science 130

Science Research Vaccine Production 130

Alta Sciences

MAY 28, 2024

Altasciences Receives 2024 CRO Leadership Award for Capabilities aasimakopoulos Wed, 05/29/2024 - 17:54 Laval, Québec, May 29, 2024 – Altasciences announced today that it has been recognized for excellence in contract research with a 2024 CRO Leadership Award for Capabilities.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Research 40

Fierce BioTech

APRIL 3, 2024

Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development dwunderlin Wed, 04/03/2024 - 17:28 Tue, 05/14/2024 - 09:30 Resource Type Webinar Dr. Sylvia F. On Demand Start Date Tue, 05/14/2024 - 10:30 Click here to login. Click here to login. Listing Image Hub_ListingLogo_250x190.png

Drug Development 52

Drug Development Drugs Therapies Treatment 52

Perficient: Drug Development

JANUARY 9, 2024

Medical device industry trends for 2024. Let’s look at what is poised to impact the medical device industry in 2024. Let’s look at what is poised to impact the medical device industry in 2024. The medical device industry is in a constant state of evolution. population will be 65 and older by the year 2060.

Production 110

Production Clinical Trials Marketing Trials 110

Perficient: Drug Development

JULY 1, 2024

We are thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the St. The anonymous survey, conducted by a renowned research firm, evaluates several key aspects of the workplace, including organizational leadership, company values, career opportunities, work-life balance, and more. Louis Post-Dispatch !

Research 64

Research 64

Perficient: Drug Development

APRIL 25, 2024

SUGCON (Sitecore User Group Conference) Europe 2024 was the second SUGCON I’ve attended, with the first just being six months ago in Minneapolis. I’ve developed real friendships with folks from literally every corner of the world and it’s only once or twice a year we get the whole “Sitecore Family” together.

Production 109

Production Engineering Marketing Research 109

Drug Discovery World

JANUARY 17, 2023

The trial is set to take place over three years, with intermediate results expected in 2024. The post First-line clinical trial marks a turning point in drug development appeared first on Drug Discovery World (DDW). Context .

Clinical Trials 130

Clinical Trials Trials Drug Development Hospitals 130

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing International 52

FDA Law Blog: Drug Discovery

MAY 19, 2024

By Sarah Wicks — On May 21, 2024, the EveryLife Foundation for Rare Diseases (ELF) will host a Scientific Workshop at the National Press Club in Washington, D.C. aimed at identifying and characterizing the challenges in developing therapies for ultra-rare diseases and conditions that affect exceedingly small populations.

Disease 59

Disease Therapies Drug Development FDA 59

PPD

MARCH 28, 2024

Through the first few months of 2024, the economic landscape is showing signs of returning to a semblance of normalcy, mirroring the pre-COVID era. According to Jeffries Equity Research, funding totals exceeded $15 billion in January and February, marking the best monthly tallies in over a year.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Discovery World

MARCH 27, 2024

Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, eg. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs).

Drugs 130

Drugs Drug Development Research Production 130

Drug Discovery World

APRIL 24, 2024

The AI Act, which bans certain AI applications that it feels threaten citizens’ rights, was approved in the European Parliament in March 2024. Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance.

Pharma R&D 130

Pharma R&D Government Regulations Drug Development 130

Perficient: Drug Development

FEBRUARY 1, 2024

The conference will take place on February 11-14, 2024, in Orlando, Florida. The SCOPE (Summit for Clinical Ops Executives) conference is a premier event in the field of clinical operations, providing a comprehensive platform for professionals to explore the latest trends and innovations in clinical research. Still not registered?

Science 59

Science Clinical Research Clinical Trials Trials 59

Drug Discovery World

MAY 1, 2024

A drop in the prices of non-human primates (NHPs) in China indicates a post-pandemic slowdown in Chinese drug development, according to a report in the Financial Times. Investment in China’s healthcare sector fell from $31 billion in 2021 to $12 billion last year, according to UBS research. The figures are taken from UBS data.

Vaccine 130

Vaccine Pharmaceuticals Drug Development Research 130

Agency IQ

MAY 3, 2024

What We Expect the FDA to do in May and June 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Regulations Clinical Trials 40

Perficient: Drug Development

MARCH 19, 2024

Our experts are closely monitoring nine healthcare trends that are shaping industry leaders’ strategies in 2024. Recommended Approach : Experience is key, especially as a growing number of consumers research care options within a competitive marketplace.

Pharmacy 52

Pharmacy Nurses Marketing Engineering 52

Drug Discovery World

APRIL 16, 2024

Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, e.g. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs).

Drugs 130

Drugs Production Drug Development Research 130

Drug Discovery World

APRIL 9, 2024

Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, e.g. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs).

Production 130

Production Drug Development Research Drugs 130

Drug Discovery World

APRIL 2, 2024

Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, e.g. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs).

Drugs 130

Drugs Science Pharmaceuticals Drug Development 130

Drug Discovery World

MARCH 4, 2024

DDW Editor Reece Armstrong speaks to Abraham Wang , Head of Marketing at Collaborative Drug Discovery (CDD) about annotated assays and the advantages they bring to research teams. RA: What advantages can better analysis into assays bring to drug developers?

Drugs 147

Drugs Drug Development Compliance Research 147

Fierce BioTech

JUNE 24, 2024

They explore new drug product capabilities in relation to cytotoxic drug development and manufacturing, therefore fully completing Lonza’s integrated ADC offering. Further, they discuss how this end-to-end approach can significantly accelerate the timeline to investigational new drug filing and beyond.

Drugs 52

Drugs Drug Development Production Research 52

Perficient: Drug Development

JANUARY 23, 2024

A few weeks back, I wrote about key trends that would impact the medical device world in 2024. This time around, I’m going to be counting down some 2024 resolutions for medical device marketers. Caregivers have a tough job, and they are very influential when it comes to product research and purchasing.

Marketing 52

Marketing Testimonials Production Science 52

Drug Discovery World

MAY 6, 2024

Even before this, however, Amsterdam was established as an important centre for drug development. In a boost to cancer research for both regions, in November 2023, Cancer Research UK and the KWF Dutch Cancer Society (KWF) announced a multi-project strategic partnership.

Drugs 147

Drugs Molecular Biology Science Clinical Trials 147

Agency IQ

MARCH 1, 2024

What We Expect the FDA to do in March and April 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Clinical Trials Regulations 40